You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

AbstractFullPdf
Aug 202112581265383
Sep 2021567569460
Oct 2021501501154
Nov 2021426427141
Dec 2021383385105
Jan 202235236896
Feb 2022392398119
Mar 2022264270174
Apr 2022241255144
May 2022241245174
Jun 2022299312142
Jul 2022468474130
Aug 2022552562155
Sep 2022590606156
Oct 2022628632132
Nov 2022430432153
Dec 2022348352111
Jan 202333833897
Feb 2023419426121
Mar 2023495497175
Apr 2023402404144
May 2023384385114
Jun 2023394395113
Jul 2023513517115
Aug 202336736793
Sep 202336636682
Oct 202335936292
Nov 2023373373127
Dec 2023403404140
Jan 2024364364145
Feb 2024332332157
Mar 2024391393217
Total13840139764861